Proxy filing
Logotype for Zymeworks Inc

Zymeworks (ZYME) Proxy filing summary

Event summary combining transcript, slides, and related documents.

Logotype for Zymeworks Inc

Proxy filing summary

18 May, 2026

Executive summary

  • The annual meeting is scheduled for December 10, 2024, with voting on director elections, executive compensation, and auditor ratification.

  • Shareholders can vote online, by phone, or by mail, with detailed instructions provided for each method.

  • Proxy materials are distributed primarily via the Internet to reduce costs and environmental impact.

  • The Board recommends voting for all director nominees, for executive compensation, and for auditor ratification.

Voting matters and shareholder proposals

  • Four Class III directors are nominated for election to serve until the 2027 annual meeting.

  • Advisory vote on executive compensation (say-on-pay) is included.

  • Ratification of KPMG LLP as auditors for the year ending December 31, 2024.

  • Shareholders may submit proposals or director nominations for the 2025 annual meeting, following advance notice and procedural requirements.

Board of directors and corporate governance

  • The Board consists of a majority of independent directors, with a lead independent director appointed due to the CEO also serving as Chair.

  • Board committees include audit, compensation, nominating and corporate governance, and research and development, each with independent members.

  • Board diversity is considered in nominations, with recent appointments reflecting a commitment to diverse backgrounds.

  • Directors are elected to staggered three-year terms, supporting continuity and stability.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more